Sera Prognostics (SERA) Gross Margin Growth (1y) (2021 - 2026)
Sera Prognostics (SERA) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -65.00 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -359.00 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 610.00 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 58.00 |
| 10 | Sera Prognostics | 100.52 Mn | 100.52 Mn | -28,000.00 | 356,842.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 356,842.00 |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | -587,759.00 |
| Jun 30, 2025 | -1.06 Mn |
| Dec 31, 2024 | -625,285.00 |
| Sep 30, 2024 | -84,622.00 |
| Jun 30, 2024 | 225,163.00 |
| Dec 31, 2023 | 151,951.00 |
| Sep 30, 2023 | 18,415.00 |
| Jun 30, 2023 | 307,402.00 |
| Mar 31, 2023 | 891,358.00 |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 828,531.00 |
| Jun 30, 2022 | 329,103.00 |
| Mar 31, 2022 | -134,696.00 |
| Dec 31, 2021 | -64,231.00 |
| Sep 30, 2021 | 938,435.00 |
| Jun 30, 2021 | 316,667.00 |